You are here

Article Text

Article menu
Download PDFPDF
Diagnosis
A fasting plasma glucose level ≥7.8 mmol/l was sensitive but not specific for identifying poor glycaemic control

https://doi.org/10.1136/ebm.5.3.94

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (1999) Diabetes Care 22, 904; Bouma M, Dekker JH, de Sonnaville JJ, et al.. How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?. Jun;. :. –7.
    OpenUrlAbstract

    
 
 QUESTION: In patients with type 2 diabetes mellitus who are not using insulin, how do fasting plasma glucose (FPG) measurements compare with those of glycosylated haemoglobin (HbA1c) in determining glycaemic control?

    Design

    Comparison of 2 laboratory tests.

    Setting

    A family practice in Amsterdam, the Netherlands.

    Patients

    1020 patients who were >40 years of age (mean age 64 y, 67% women), had type 2 diabetes (median duration 2.4 y), were not pregnant, and were not taking insulin.

    Description of test and diagnostic standard

    FPG levels were measured in venous plasma by the glucose oxidase method (Boehringer-Mannheim, Mannheim, Germany) and by the glucose dehydrogenase method (Merck, Darmstadt, Germany). HbA1c was measured using high performance liquid chromatography. The sensitivity and specificity of an FPG level of 7.8 mmol/l was calculated with reference to the HbA1c diagnostic standard cut points of 6.5% and 7.0%. These cut points …

    View Full Text